| Insulin resistance syndrome blunts the mitochondrial anabolic response following resistance exercise. | |
| | |
MedLine Citation:
|
PMID: 20606077 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Metabolic risk factors associated with insulin resistance syndrome may attenuate augmentations in skeletal muscle protein anabolism following contractile activity. The purpose of this study was to investigate whether or not the anabolic response, as defined by an increase in cumulative fractional protein synthesis rates (24-h FSR) following resistance exercise (RE), is blunted in skeletal muscle of a well-established rodent model of insulin resistance syndrome. Four-month-old lean (Fa/?) and obese (fa/fa) Zucker rats engaged in four lower body RE sessions over 8 days, with the last bout occurring 16 h prior to muscle harvest. A priming dose of deuterium oxide ((2)H(2)O) and (2)H(2)O-enriched drinking water were administered 24 h prior to euthanization for assessment of cumulative FSR. Fractional synthesis rates of mixed (-5%), mitochondrial (-1%), and cytosolic (+15%), but not myofibrillar, proteins (-16%, P = 0.012) were normal or elevated in gastrocnemius muscle of unexercised obese rats. No statistical differences were found in the anabolic response of cytosolic and myofibrillar subfractions between phenotypes, but obese rats were not able to augment 24-h FSR of mitochondria to the same extent as lean rats following RE (+14% vs. +28%, respectively). We conclude that the mature obese Zucker rat exhibits a mild, myofibrillar-specific suppression in basal FSR and a blunted mitochondrial response to contractile activity in mixed gastrocnemius muscle. These findings underscore the importance of assessing synthesis rates of specific myocellular subfractions to fully elucidate perturbations in basal protein turnover rates and differential adaptations to exercise stimuli in metabolic disease. |
| | |
Authors:
|
Mats I Nilsson; Nicholas P Greene; Justin P Dobson; Michael P Wiggs; Heath G Gasier; Brandon R Macias; Kevin L Shimkus; James D Fluckey |
Related Documents
:
|
19631477 - Exercise-induced reduction in systemic vascular resistance: a covert killer and an unre... 6698677 - Delayed muscle soreness and cytoskeletal alterations: an immunocytological study in man. 11601507 - Multisystem disorder associated with a missense mutation in the mitochondrial cytochrom... 21070797 - Heavy resistance exercise training and skeletal muscle androgen receptor expression in ... 2127017 - Comparison of arterial, end-tidal and transcutaneous pco2 during moderate exercise and ... 3618807 - Time course of aerobic recovery after contraction of rabbit papillary muscle. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-07-06 |
Journal Detail:
|
Title: American journal of physiology. Endocrinology and metabolism Volume: 299 ISSN: 1522-1555 ISO Abbreviation: Am. J. Physiol. Endocrinol. Metab. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-26 Completed Date: 2010-10-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100901226 Medline TA: Am J Physiol Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: E466-74 Citation Subset: IM |
Affiliation:
|
Dept. of Health and Kinesiology, Texas A & M University, College Station, 77843-4243, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cohort Studies Insulin Resistance / physiology* Male Mitochondria, Muscle / metabolism* Mitochondrial Proteins / biosynthesis* Muscle Contraction / physiology Muscle Proteins / biosynthesis* Muscle, Skeletal / metabolism* Physical Conditioning, Animal / physiology* Rats Rats, Zucker Statistics, Nonparametric |
| Chemical | |
Reg. No./Substance:
|
0/Mitochondrial Proteins; 0/Muscle Proteins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Palmitic acid acutely inhibits acetylcholine- but not GLP-1-stimulated insulin secretion in mouse pa...
Next Document: Disclosing a diagnosis of cancer: where and how does it occur?